West Pharmaceuticals Showcases SelfDose Injector at CPHI Worldwide…

Event summary

West Pharmaceuticals to showcase SelfDose® patient-controlled injector at CPHI Worldwide in Milan, Italy, October 5-7, 2026.
Company to present on strategic CDMO partnerships and large volume drug delivery trade-offs.
Shane Campbell, Senior Vice President and Chief Proprietary Segment Officer, highlights West's century-long partnership with leading pharmaceutical companies.
West generated $3.07 billion in net sales in fiscal year 2025.

The big picture

West Pharmaceuticals is positioning itself as a leader in patient-centered drug delivery solutions. The company's focus on strategic partnerships and innovative product development aligns with broader industry trends towards personalized and convenient drug administration. With a strong financial performance in fiscal year 2025, West is well-positioned to capitalize on the growing demand for advanced injectable drug solutions.

What we're watching

Product Differentiation: How West's SelfDose® injector will compete in the growing patient-controlled drug delivery market.
Strategic Partnerships: Whether West can leverage its CDMO partnerships to accelerate time-to-market for combination drug-device products.
Market Expansion: The pace at which West can expand its global footprint with innovative packaging and containment solutions.